Genome analysis available to individuals

Nov 20, 2007

A laboratory in Germany said Monday it will make genome sequencing available to private individuals, the first European company to do so.

GATC Biotech AG in Constance will offer a routine analysis of human genomes, making it possible for people to have their genetic make-up decoded, the company said in a news release. The service still will focus primarily on the research sector and the pharmaceutical industry.

"Our aim is to decode a total of 100 human genomes by the end of 2010, says Peter Pohl, GATC Biotech chief executive said. "The findings obtained will be of use to the medical research sector and will result in significant advances in this field."

The cost of a standard analysis is about $73,300, while one producing medical-value results would cost nearly $1.5 million. Board member Markus Benz said he expects the price to fall over time.

"If the price comes down, it will be possible in the future to use the technology for diagnostic purposes in the same way as X-ray technology is used today," Benz said.

Copyright 2007 by United Press International

Explore further: Down's chromosome cause genome-wide disruption

add to favorites email to friend print save as pdf

Related Stories

NREL Evaluates UPS Hybrid-Electric Van Performance

Dec 22, 2009

(PhysOrg.com) -- The U.S. Department of Energy's National Renewable Energy Laboratory (NREL) has collected and analyzed fuel economy, maintenance and other vehicle performance data from UPS’s first generation hybrid diesel ...

Recommended for you

Down's chromosome cause genome-wide disruption

9 hours ago

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

Research uncovers DNA looping damage tied to HPV cancer

15 hours ago

It's long been known that certain strains of human papillomavirus (HPV) cause cancer. Now, researchers at The Ohio State University have determined a new way that HPV might spark cancer development – by ...

New therapy against rare gene defects

Apr 15, 2014

On 15th April is the 1st International Pompe Disease Day, a campaign to raise awareness of this rare but severe gene defect. Pompe Disease is only one of more than 40 metabolic disorders that mainly affect children under ...

User comments : 0

More news stories

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

More vets turn to prosthetics to help legless pets

A 9-month-old boxer pup named Duncan barreled down a beach in Oregon, running full tilt on soft sand into YouTube history and showing more than 4 million viewers that he can revel in a good romp despite lacking ...